亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北遠成藥業有限公司(武漢)  

精細化工,香精香料,食品添加劑,醫藥原料及中間體等產品

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:顧亞男
  • 電話:027-50756114
  • 郵件:ycmanagers06@ycphar.com
  • 傳真:027-88048077
  • QQ:2355327070
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 雙氯芬酸鈉
雙氯芬酸鈉
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
庫存 4000KG起訂1KG
品牌 南箭
過期 長期有效
更新 2015-02-12 11:54
 
詳細信息
中文名稱: 雙氯芬酸鈉
中文同義詞: 二氯芬酸;2-[(2,6-二氯苯基)氨基]-禁發 苯乙酸鈉;雙氯芬酸鈉;雙氯滅痛;雙氯芬酸乙酯;服他靈;雙氯胺禁發 苯乙酸鈉;雙氯滅痛鈉
英文名稱: Diclofenac sodium
CAS號: 15307-79-6
分子式: C14H10Cl2NNaO2
分子量: 318.13
EINECS號: 239-346-4
相關類別: Active Pharmaceutical Ingredients;Organics;Intermediates & Fine Chemicals;Pharmaceuticals;Steroids;API's;Lipid signaling;Amines;Aromatics;Heterocycles;原料藥
Mol文件: 15307-79-6.mol
熔點  288-290°C
儲存條件  -20°C Freezer
溶解度  H2O: 50 mg/mL
化學性質  無色結晶性粉末。熔點283-285℃,游離酸熔點156-158℃。
用途  該品為強效解熱鎮痛消炎藥。其消炎作用是吲哚美辛的2-2.5倍,較乙酰水楊酸強26-50倍。適用于類風濕性關節炎、骨關節病、手術后止痛及各種原因引起的發熱。
©2025 湖北遠成藥業有限公司(武漢) 版權所有   技術支持:化工網   訪問量:20115  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |